Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis.
Genome-wide approaches for identifying interacting susceptibility regions for asthma.
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years? Clin Liver Dis. 2020 11; 24(4):681-700.
View in:
PubMed
subject areas
Ablation Techniques
Brachytherapy
Carcinoma, Hepatocellular
Chemoembolization, Therapeutic
Hepatectomy
Humans
Liver Neoplasms
Liver Transplantation
Radiosurgery
Radiotherapy
authors with profiles
Anjana Pillai